Link Silicon Valley
The fastest way to connect to the people, companies and capital of Silicon Valley
Free 30 Day Trial Account
Sign Up | Log In
Search
ACQUIRED COMPANY
 
My Lists

Genentech  (Stock symbol: DNA ) Acquired by Roche (2009 $ 46,800,000,000 )

1 DNA Way
South San Francisco, CA 94080
USA
(650)-225-1000
Website Company Summary Management Team
Board

Outside board: (May no longer be on the board) Herbert W. Boyer (Genentech) William M. Burns (Roche Division CEO) Erich Hunziker (The Roche Group CFO) Jonathan K. C. Knowles (The Roche Group Division President) Donna L. Reed (San Diego Gas & Electric and Southern California Gas Co. President/CEO) Charles Sanders (Glaxo Former CEO/Chairman) Arthur D. Levinson (Genentech Former President/CEO)
Former outside board: Tom Perkins (Kleiner Perkins)
Company

Business description: Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes biotherapeutics for significant unmet medical needs. Delivering innovative medicines to patients with serious or life-threatening medical conditions is what Genentech is all about. Today, Genentech manufactures and commercializes 10 protein-based products for serious or life-threatening medical conditions -- giving Genentech one of the leading product portfolios in the biotech industry. Our focus is on developing innovative therapies that fill significant unmet medical needs and positively impact the world of human health. Genentech currently manufactures and commercializes 12 products in the United States for a variety of medical conditions, including cancer, heart attack, allergic asthma, psoriasis, stroke, growth hormone deficiency and cystic fibrosis.
Partners include: AbgenixActelionAdaptive Biotechnologies AlkermesAmgenConneticsCOR TherapeuticsGenVecGlycomedImmunoGenIncyteInterMuneNovartisRocheSeattle GeneticsSurModicsVaxgen (renamed DiaDexus, see DiaDexus)Xoma;  Aventis SA;  Biogen;  Boehringer Ingelheim;  Cambridge Antibody Technology;  DAKO;  Genetics Institute;  Hanmi;  Human Genome;  IDEC;  Lonza;  Lonza Group ;  Millennium;  OSI;  PharmaciaAndUpjohn;  Schering;  Scios Nova;  Sensus Corporation;  Sumitomo Pharmaceuticals Corp.: ;  Urogenesys
Capital

Ownership: Acquired by Roche (2009 $ 46,800,000,000 )
Stock Symbol: DNA

Last Tweets


 

Last Mentions


Overview
Record updated: Dec 2016
Sector: Biotech
Headcount: 7001-10000 as of May 2008
Ownership: Acquired by Roche (2009 $ 46,800,000,000 )
Stock Symbol: DNA